Skip to main content
Equibles

Joshua R. Disbrow

CEO

Aytu Biopharma, Inc (AYTU)

Board Member

ZYNEX INC (ZYXIQ)

Board Member

Aytu Biopharma, Inc (AYTU)

Equibles does not estimate personal net worth.

Get an email with a short summary when Aytu Biopharma, Inc publishes a filing, an earnings call transcript or a press release.

Get AYTU alerts

About Joshua R. Disbrow

Joshua R. Disbrow is recorded as Board Member at Aytu Biopharma, Inc (AYTU) since January 1, 2016, CEO at Aytu Biopharma, Inc (AYTU) and Board Member at ZYNEX INC (ZYXIQ) since January 1, 2018. The newest filing on record that lists Joshua R. Disbrow as CEO and Board Member at Aytu Biopharma, Inc (AYTU) is dated October 22, 2026. The newest filing on record that lists Joshua R. Disbrow as Board Member at ZYNEX INC (ZYXIQ) is dated March 28, 2025. The proxy statement of Aytu Biopharma, Inc reports total compensation of $844,854 for Joshua R. Disbrow in fiscal 2026, including a base salary of $608,154. Disclosed compensation is on record for 8 fiscal years. Joshua R. Disbrow has spoken on 2 earnings calls across 1 company, most recently for Aytu Biopharma, Inc on November 13, 2025. Aytu Biopharma, Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. ZYNEX INC is classified in the Medical Distribution industry within the Healthcare sector. Other leadership on record at Aytu Biopharma, Inc includes John A. Donofrio, Jr. (Chairman), Gregory A. Gould (CFO), Ryan Selhorn (CFO) and 7 others.

Joshua R. Disbrow on recent calls

“I'm excited to be speaking with you after a very positive and productive first quarter. Let’s highlight the key points.”
CEO, Aytu Biopharma, Inc Q1 FY2026 Earnings Call ·
“I'm extremely pleased to be speaking with you today following the release of our fiscal '24 second quarter financial results, which culminated in our first quarter of positive operating income in company history.”
CEO, Aytu Biopharma, Inc Q2 FY2024 Earnings Call ·

Affiliation history

Company network

ZYNEX INC

ZYXIQ

Current role

Medical Distribution · Healthcare

Board Member

2018-01-01–present

Leadership on record at Aytu Biopharma, Inc

Leadership on record at ZYNEX INC

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2026 Aytu Biopharma, Inc (AYTU) $608,154 $844,854
2025 Aytu Biopharma, Inc (AYTU) $590,000 $883,928
2024 Aytu Biopharma, Inc (AYTU) $590,000 $928,217
2023 Aytu Biopharma, Inc (AYTU) $590,000 $708,000
2022 Aytu Biopharma, Inc (AYTU) $590,000 $590,000
2020 Aytu Biopharma, Inc (AYTU) $607,620 $1,585,450
2019 Aytu Biopharma, Inc (AYTU) $330,000 $1,043,705
2018 Aytu Biopharma, Inc (AYTU) $303,000 $606,000

Recent activity